Increased cutaneous squamous cell carcinoma risk with hydrochlorothiazide use: is there a safe alternative?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Increased cutaneous squamous cell carcinoma risk with hydrochlorothiazide use: is there a safe alternative?

Published:2021-07-05 Issue:2 Volume:185 Page:244-245
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Hollestein L.M.¹²^ORCID,Arnspang Pedersen S.³⁴^ORCID

Affiliation:

1. Erasmus MC Cancer Institute Department of Dermatology Rotterdam the Netherlands

2. Netherlands Comprehensive Cancer Organization (IKNL) Department of Research Utrecht the Netherlands

3. Danish Medicines Agency Regulatory & Clinical Assessment Copenhagen Denmark

4. University of Southern Denmark Department of Public Health Odense Denmark

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjd.20526

Reference9 articles.

1. Association between hydrochlorothiazide and the risk of in situ and invasive squamous cell skin carcinoma and basal cell carcinoma: A population-based case-control study

2. Risk of squamous cell carcinoma of the lip and cutaneous melanoma in older Australians using hydrochlorothiazide: A population‐based case‐control study

3. Hydrochlorothiazide Use and Increased Squamous Cell Carcinoma Burden in a High-Risk Mohs Population: A Cross-Sectional Study

4. Hydrochlorothiazide use and risk of non-melanoma skin cancer in Spain: A case/non-case study

5. Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case-control study from Denmark

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Does systemic hydrochlorothiazide increase the risk of developing ultraviolet radiation‐induced skin tumours in hairless mice?;Experimental Dermatology;2022-11-18

2. A reverse translational pharmacological approach to understand the underlying mechanisms of the reported association between hydrochlorothiazide and non-melanoma skin cancer;Journal of Hypertension;2022-07-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3